NRSA Postdoctoral Fellow
Michael W. Mullowney is an NRSA Postdoctoral Fellow through the National Cancer Institute (NCI) at the National Institutes of Health (NIH) working under the co-mentorship of Prof. Neil L. Kelleher and Prof. Regan J. Thomson. He earned his PhD in Pharmacognosy in 2016 as an AFPE and NIH NCCIH T32 predoctoral fellow in the lab of Prof. Brian T. Murphy at the University of Illinois at Chicago, where he discovered novel tuberculosis antibiotic leads from freshwater- and marine-derived actinomycete bacteria. Dr. Mullowney’s postdoctoral research involves the advancement of “metabologenomics,” a platform that correlates microbial genomics and mass-spectrometry–based metabolomics to drive the discovery of novel specialized metabolites. Specifically, he is applying metabologenomics toward the targeted discovery of novel anti-cancer drug leads and the investigation of specialized metabolites from microbes in underexplored ecological niches. In addition, Michael is the founder and co-chair of the Science Policy Outreach Task Force (SPOT), an organization at Northwestern University dedicated to advocating for science and evidence-based decision-making to voters and policymakers.